References
- Lindstorm J M, Seybolt M E, Lennon V A, Whittingham S, Duana D D. Antibody to acetylocholine receptor in myasthenia gravis: Prevalence, clinical correlates and diagnostic value. Neurology 1976; 26: 1054–1059
- Rosenow E CI, II, Hurley B T. Disorders of the thymus. A review. Arch Intern Med 1984; 144: 763–770
- Buckingham J M, Howard F H, Bernatz P E, Payne W S, Harrison E G, O'Brien P C, et al. The value of thymectomy in myasthenia gravis: A computer matched study. Ann Surg 1976; 184: 453–458
- Arimori S, Nakata Y, Tada S, Kobashi H, Ichikawa Y, Koriyama K. Studies on lymphocyte subpopulations and their responses to mitogenic stimulations of myasthenic patients. Keio J Med 1975; 24: 311–334
- Sandilands G P, Gray K, Cooney A, Anderson J R, Simpson J A, Behan P O. Rosette tests following thymectomy. Lancet 1975; i: 171–172
- Shirai T, Miyata M, Nakase A, Itoh T. Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and blood of patients with myasthenia gravis. Clin Exp Immunol 1976; 26: 118–123
- Berrih S, Gaud C, Bach M-A, Brigand H L, Binet J P, Bach J F. Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies. Clin Exp Immunol 1981; 45: 1–8
- Miller A E, Hudson J, Tindall R SA. Immune regulation in myasthenia gravis: Evidence for an increased suppressor T-cell population. Ann Neurol 1982; 12: 341–347
- Skolnik P R, Lisak R P, Zweiman B. Monoclonal antibody analysis of blood T-cell subsets in myasthenia gravis. Ann Neurol 1982; 11: 170–176
- Berrih S, Brigand H L, Lavasseur P, Gaud C, Bach J-F. Depletion of helper/inducer T cells after thymectomy in myasthenic patients. Clin Immunol Immunopathol 1983; 28: 272–281
- Haynes B F, Harden E A, Olanow C W, Eisenbarth G S, Wechsler A S, Hensley L L, et al. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: Selective effect on T-cell in patients with thymic atrophy. J Immunol 1983; 131: 773–777
- Cox A, Lisak R P, Skolnik P, Zweiman. Effect of thymectomy on blood T-cell subsets in myasthenia gravis. Ann Neurol 1986; 19: 297–298
- Machi M, Itoyama Y, Goto I, Kuroiwa Y. Surface phenotypes of lymphoid cells altered in the human myasthenia thymus. Neurology 1988; 38: 592–596
- Ichikawa Y, Shimizu H, Takahashi K, Yoshida M, Moriuchi J, Takaya M, et al. Lymphocyte subsets of the peripheral blood in Sjögren's syndrome and rheumatoid arthritis. Clin Exp Rheumatol 1989; 7: 55–61
- Gatenby P A, Kansas G S, Xian C Y, Evans R L, Engleman E G. Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man. J Immunol 1982; 129: 1977–2000
- Lanier U, Engleman E G, Gatenby P, Babcock G F, Warner N L, Herzenberg L A. Correlation of functional properties of human lymphoid cell subsets and surface marker phenotypes using mul-tiparameter analysis and flow cytometry. Immunol Rev 1983; 74: 143–160
- Landay A, Gartland G L, Clement L T. Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppress T cell proliferative responses. J Immunol 1983; 31: 2757–2761
- Clement L T, Dagg M K, Landay A. Characterization of human lymphocyte subpopulations: alloreac-tive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu2 + suppressor cells. J. Clin lmmunol 1984; 4: 395–402
- Clement L T, Grossi C E, Gartland L. Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation. J Immunol 1984; 133: 2461–2468
- Takeuchi T, DiMaggio M, Levine H, Schlossman S F, Morimoto C. CD 11 molecule defines two types of suppressor cells within the T8+ population. Cell Immunol 1988; 111: 398–409
- Lanier L L, Le A M, Phillips J H, Warner N L, Babcock G F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (NHK-1) and Leu-11 (NK-15) antigens. J lmmunol 1983; 131: 1789–1796
- Aarli J A, Heimann P, Matre R, Thunold S, Tonder O. Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis. J Neurol Neurosurg Psychiat 1979; 42: 29–34
- Russo L, Scoppetta C, Tonali P. Shifting of the blood T:B lymphocyte ratio in myasthenia gravis patients after thymectomy. Neurology 1977; 27: 642–645
- Ichikawa Y, Nakata Y, Koriyama K, Komatsuda M, Arimori S, Kobashi H, et al. The continuous treatment of generalized myasthenia gravis with small doses of prednisolone with or without immunosuppressants. Nippon Naika Gakkai Zashi 1976; 65: 669–680, in Japanese
- Newson-Davis J, Willcox N, Calder L. Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autolougous blood lymphocytes. N Engl J Med 1981; 26: 1313–1318